Zobrazeno 1 - 10
of 91
pro vyhledávání: '"P B, McGlave"'
Autor:
M. Tomblyn, Jeffrey S. Miller, Tyson B. Rogers, Daniel J. Weisdorf, Bruce R. Blazar, Linda J. Burns, P B McGlave, John E. Wagner, Charlotte P. Lee
Publikováno v:
Bone Marrow Transplantation. 40:111-118
Hematopoietic growth factors alone or in combination with myelosuppressive chemotherapy are used to mobilize peripheral blood stem cells for autologous transplantation. To identify characteristics of successful mobilization with granulocyte colony-st
Autor:
Leslie L. Robison, David D. Smith, Andrea Carter, P B McGlave, K. S. Baker, Marcia Grant, Daniel J. Weisdorf, Smita Bhatia, Liton Francisco, James G. Gurney, Stephen J. Forman
Publikováno v:
Bone Marrow Transplantation. 37:1023-1029
We conducted a retrospective study to describe the magnitude of compromise in reproductive function and investigate pregnancy outcomes in 619 women and partners of men treated with autologous (n=241) or allogeneic (n=378) hematopoietic cell transplan
Autor:
J.S. Miller, Todd E. DeFor, Daniel J. Weisdorf, J N Barke, Linda J. Burns, P B McGlave, Mukta Arora
Publikováno v:
Bone Marrow Transplantation. 35:1133-1140
We compared the results of autologous and allogeneic peripheral blood hematopoietic cell transplant (HCT) in 87 patients with multiple myeloma using myeloablative preparative regimen. Autologous transplant (n=70) led to a lower 100-day transplant-rel
Autor:
P B McGlave, Stella M. Davies, Todd E. DeFor, Jeffrey S. Miller, John E. Wagner, Daniel J. Weisdorf, Catherine M. Verfaillie
Publikováno v:
The American Journal of Medicine. 110:339-346
PURPOSE: To determine if the favorable outcomes after transplantation of matched sibling donor bone marrow in patients with chronic myelogenous leukemia can be achieved using bone marrow from an HLA-A,B/DRB1-matched unrelated donor. SUBJECTS AND METH
Autor:
Stella M. Davies, Paul Browne, Wesley J. Miller, P B McGlave, Daniel J. Weisdorf, Helen Enright, Todd E. DeFor, N. K. C. Ramsay, Alexandra H. Filipovich, John E. Wagner
Publikováno v:
Bone Marrow Transplantation. 26:865-869
Chronic graft-versus-host disease (GVHD) refractory to standard immunosuppressive therapy remains a major cause of morbidity and mortality after allogeneic bone marrow transplantation (BMT). Thalidomide may be effective in some patients with high-ris
Autor:
R. S. Shapiro, John E. Wagner, Alexandra H. Filipovich, P B McGlave, M. Steinbuch, N. K. C. Ramsay, Thomas G. Gross, T. Defor
Publikováno v:
Bone Marrow Transplantation
Twenty-six cases of B cell lymphoproliferative disorder (BLPD) were identified among 2395 patients following hematopoietic stem cell transplants (HSCT) for which an overall incidence of BLPD was 1.2%. The true incidence was probably higher, since 9/2
Autor:
Emmanuel Katsanis, Bruce R. Blazar, John H. Kersey, Todd E. DeFor, John E. Wagner, Daniel J. Weisdorf, P B McGlave, Stella M. Davies, Paul J. Orchard, Norma K.C. Ramsay
Publikováno v:
British Journal of Haematology. 96:749-756
Allogeneic transplantation from an HLA-matched family member has been shown to be effective in reconstituting normal haemopoiesis in young people with severe cytopenias, classified as myelodysplastic syndrome (MDS) or severe aplastic anaemia (SAA). u
Autor:
Daniel J. Weisdorf, Norma K.C. Ramsay, Stella M. Davies, Alexandra H. Filipovich, J. H. Kersey, P B McGlave, J Burroughs, Catherine M. Verfaillie, John E. Wagner, Jeffrey S. Miller
Publikováno v:
Blood. 85:3452-3456
Delay in hematologic recovery after bone marrow transplantation (BMT) can extend and amplify the risks of infection and hemorrhage, compromise patients' survival, and increase the duration and cost of hospitalization. Because current studies suggest
Publikováno v:
Blood. 84:1802-1811
Close interaction of human hematopoietic progenitors with the bone marrow microenvironment is important for the ordered progression of human hematopoiesis. Progenitor cell adhesion to stroma has a complex molecular basis, involving various cell-extra
Publikováno v:
Journal of Clinical Investigation. 94:384-391
Treatment of chronic myelogenous leukemia (CML) with interferon-alpha frequently results in normalization of peripheral blood counts and, in up to 20% of patients, reestablishment of normal hematopoiesis. We hypothesize that interferon-alpha may rest